P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells

Molecular and Cellular Biochemistry

Volumn 395, Issue 1-2, 2014, Pages 281-290

  Kumar, Sanjay ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

G2 M arrest; HIC1; P21; P27; P53; Tumor suppressor; U87MG

Indexed keywords

PROTEIN P21; PROTEIN P27; PROTEIN P53; SMALL INTERFERING RNA; HIC1 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; TP53 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GLIOBLASTOMA CELL LINE; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERMETHYLATED IN CANCER 1 GENE; MTT ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE; BRAIN TUMOR; CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; TUMOR CELL LINE;

ANIMALIA;

BRAIN NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84921651890     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2137-9     Document Type: Article

References (37)

1. Parrella P, Scintu M, Prencipe M, Poeta ML, Gallo AP, Rabitti C, Rinaldi M, Tommasi S, Paradiso A, Schittulli F, Valori VM, Toma S, Altomare V, Fazio VM (2005) HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. Cancer Lett 222:75-81 (Pubitemid 40544849)
2. Zhang W, Zeng X, Briggs KJ, Beaty R, Simons B, Chiu Yen RW, Tyler MA, Tsai HC, Ye Y, Gesell GS, Herman JG, Baylin SB, Watkins DN (2010) A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. Oncogene 29:2467-2476
3. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB (1992) Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci 89:1929-1933
4. Makos M, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM, Baylin SB (1993) DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res 53:2715-2718 (Pubitemid 23180502)
5. Rood BR, Zhang H, Weitman DM, Cogen PH (2002) Hypermethylation of HIC1 and 17p allelic loss in medulloblastoma. Cancer Res 62:3794-3797 (Pubitemid 34728863)
6. Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, Isaacs W, Linehan M, Baylin SB (1993) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 53:2719-2722 (Pubitemid 23180503)
7. Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB, Gabrielson E (1998) Methylation of the HIC1 candidate tumor suppressor gene in human breast cancer. Oncogene 16:2159-2164 (Pubitemid 28211691)
8. Kanai Y, Ushijima S, Ochiai A, Eguchi K, Hui A, Hirohashi S (1998) DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett 122:135-141 (Pubitemid 28058628)
9. Morton RA Jr, Watkins JJ, Bova GS, Wales MM, Baylin SB, Isaacs WB (1996) Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue. J Urol 156:512-516 (Pubitemid 126445370)
10. Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE, Bosl GJ, Chaganti RS, Murty VV (2002) Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer 1:1-8
11. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA, Baylin SB (1997) HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res 57:1678-1681 (Pubitemid 27199658)
12. Melki JR, Vincent PC, Clark SJ (1999) Cancer-specific region of hypermethylation identified within the HIC1 putative tumor suppressor gene in acute myeloid leukaemia. Leukemia 13:877-883 (Pubitemid 29292138)
13. Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S (1997) Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumors. Oncogene 15:871-874 (Pubitemid 27390140)
14. Sarkar C, Karak AK, Nath N, Sharma MC, Mahapatra AK, Chattopadhyay P, Sinha S (2005) Apoptosis and proliferation: correlation with p53 in astrocytic tumors. J Neurooncol 73:93-100 (Pubitemid 40974028)
15. Sarkar C, Sinha S, Sharma MC, Kumar R, Mehta VS (2004) Supratentorial glioblastoma in adults: identification of subsets and their clinical correlation. Brain Tumor Pathol 21:7-12 (Pubitemid 38915176)
16. Fleuriel C, Touka M, Boulay G, Guérardel C, Rood BR, Leprince D (2009) HIC1 (hypermethylated in cancer 1) epigenetic silencing in tumors. Int J Biochem Cell Biol 41:26-33
17. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB (1995) p53 activates expression of HIC1, a new candidate tumor suppressor gene on 17p13.3. Nat Med 1:570-577
18. Mondal AM, Chinnadurai S, Datta K, Chauhan SS, Sinha S, Chattopadhyay P (2006) Identification and functional characterization of a novel unspliced transcript variant of HIC1 in human cancer cells exposed to adverse growth conditions. Cancer Res 66:10466-10477 (Pubitemid 44799768)
19. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB (2003) Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33:197-202 (Pubitemid 36177074)
20. Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, Vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP (2009) The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Mol Cancer Res 7:916-922
21. Zhang B, Chambers KJ, Leprince D, Faller DV, Wang S (2009) Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control. Oncogene 28:651-656
22. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123:437-448 (Pubitemid 41546674)
23. Peng X, Maruo T, Matsuo H, Takekida S, Deguchi J (1998) Serum deprivation-induced apoptosis in cultured porcine granulosa cells is characterized by increased expression of p53 protein, Fas antigen and Fas ligand and by decreased expression of PCNA. Endocr J 45:247-253 (Pubitemid 28259405)
24. Datta K, Shah P, Srivastava T, Mathur SG, Chattopadhyay P, Sinha S (2004) Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotides. Cancer Gene Ther 11:525-531 (Pubitemid 39079490)
25. Pinte S, Stankovic-Valentin N, Deltour S, Rood BR, Guerardel C, Leprince D (2004) The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J Biol Chem 279:38313-38324 (Pubitemid 39295979)
26. Maxwell SA, Mukhopadhyay T (1994) Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid. Exp Cell Res 214:67-74 (Pubitemid 24302378)
27. Maki CG, Huibregtse JM, Howley PM (1996) In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res 56:2649-2654 (Pubitemid 26170702)
28. Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y (1990) Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 336:761-763 (Pubitemid 20312184)
29. Levine AJ (1997) p53: the cellular gatekeeper for growth and division. Cell 88:323-331
30. Wang X, Gao P, Long M, Lin F, Wei JX, Ren JH, Yan L, He T, Han Y, Zhang HZ (2011) Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol 28:1225-1254
31. Manna SK, Bose JS, Gangan V, Raviprakash N, Navaneetha T, Raghavendra PB, Babajan B, Kumar CS, Jain SK (2010) Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB. J Biol Chem 285:22318-22327
32. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245
33. Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J, Qin Y, Sun Z, Zheng X (2010) miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10:354
34. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
35. Artavanis-Tsakonas S, Matsuno K, Fortini ME (1995) Notch signaling. Science 26:225-232
36. Fre S, Pallavi SK, Huyghe M, Laé M, Janssen KP, Robine S, Artavanis-Tsakonas S, Louvard D (2009) Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci 106:6309-6314
37. Sade H, Krishna S, Sarin A (2004) The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J Biol Chem 279:2937-2944 (Pubitemid 38114286)